Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Echelon Biosciences
Salt Lake City, Utah, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Echelon Biosciences produces commercial research reagents and assays focused on lipid signaling, cell signaling, and biochemical targets involved in cancer, neurodegeneration, and metabolic disease. Its products are used in preclinical and translational research, not directly for patient clinical trials.
- Therapeutic areas
- OncologyNeurologyMetabolic DisordersImmunology
- Modalities
- AntibodyPeptidesProteinsSmall moleculeLipid nanoparticle delivery therapyAssay kits
- Industry
- Chemicals & Materials
02
Partnerships
Frontier Scientific (merger/acquisition)Hyalose, LLC (distribution partnership)
Beyond the preview
Go deeper on Echelon Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Echelon Biosciences.